Intensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
Figure 2
Freedom from relapse of 60 patients with hypopharyngeal-laryngeal cancer.